drugset / Trial / NCT04395768

International ALLIANCE Study of Therapies to Prevent Progression of COVID-19

NCT04395768

RandomizedParallel-groupDouble-blindTreatment

Summary

COVID-19 is a global pandemic. So far encouraging results have been shown in different parts of the world with the utilisation of hydroxycloroquine, zinc, and azithromycin, and early studies into some of these, plus some with Vitamin C, have also proven beneficial. Vitamin D levels have also been shown to be an important indicator to the severity of symptoms in COVID-19 patients.

Timeline

Start
2020-09-09
Primary completion
2021-09-30
Completion
2021-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Azithromycin Small molecule 250 mg Oral
Subject Hydroxychloroquine Small molecule 200 mg Oral

Indications